SCHEMBL17547381

SCHEMBL17547381

C=C(C)COc1cc(-c2ccc(OC(=O)C(=C)C)c(OCC(=C)C)c2)ccc1OC(=O)C(=C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.43
KDM4E B2RXH2 6/20 0.39
MAPT P10636 6/20 0.39
ALDH1A1 P00352 5/20 0.39
HPGD P15428 2/20 0.39
PDE4A P27815 3/20 0.39
PDE4B Q07343 3/20 0.39
PDE4C Q08493 3/20 0.39
PDE4D Q08499 3/20 0.39
CFD P00746 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
HSD17B10 Q99714 3/20 0.38
LMNA P02545 2/20 0.38
TSHR P16473 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
POLB P06746 1/20 0.38
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17546997 0.98 AKR1C3 (0.42) AKR1C3KDM4EMAPTALDH1A1HPGD
SCHEMBL17546888 0.97 AKR1C3 (0.41) AKR1C3KDM4EMAPTALDH1A1HPGD
SCHEMBL17547000 0.96 AKR1C3 (0.41) AKR1C3KDM4EMAPTALDH1A1HPGD
SCHEMBL25572041 0.93 ELANE (0.43) AKR1C3KDM4EMAPTALDH1A1HPGD
SCHEMBL17546934 0.90 KDM4E (0.39) AKR1C3KDM4EMAPTALDH1A1HPGD
SCHEMBL17546862 0.88 GAPDH (0.39) AKR1C3KDM4EMAPTALDH1A1HPGD
SCHEMBL17546758 0.88 GAPDH (0.37) AKR1C3KDM4EMAPTALDH1A1HPGD
SCHEMBL21469992 0.87 ELANE (0.43) AKR1C3KDM4EMAPTALDH1A1HPGD
SCHEMBL23045941 0.85 FFAR1 (0.39) KDM4EMAPTALDH1A1HPGD
SCHEMBL15329543 0.85 CFD (0.46) KDM4EMAPTALDH1A1CFDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2990424-B1 POLYMERIZABLE COMPOUND AND POLYMERIZABLE COMPOSITION JNC CORP (JP) 2019-01-30 EP disclosed
EP-3327045-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC Corporation (JP) 2018-05-30 EP disclosed
US-20160075950-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2016-03-17 US disclosed
EP-2990424-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT JNC Corporation (JP) 2016-03-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160075950-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE PYM1, DRD1, PLD1 AKR1C3 3335/4885KDM4E 3191/4885MAPT 1879/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.